The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls by Safita, Novie et al.
 DRO  
Deakin Research Online, 
Deakin University’s Research Repository  Deakin University CRICOS Provider Code: 00113B 
The impact of type 2 diabetes on health related quality of life in Bangladesh: results 
from a matched study comparing treated cases with non-diabetic controls 
Citation:  
Safita, Novie, Islam, Sheikh Mohammed Shariful, Chow, Clara K., Niessen, Louis, Lechner, Andreas, 
Holle, Rolf and Laxy, Michael 2016, The impact of type 2 diabetes on health related quality of life in 
Bangladesh: results from a matched study comparing treated cases with non-diabetic controls, 
Health and quality of life outcomes, vol. 14, Article number: 129, pp. 1-9. 
DOI: https://doi.org/10.1186/s12955-016-0530-7 
 
 
 
 
 
©2017, The Authors 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
Downloaded from DRO:  
http://hdl.handle.net/10536/DRO/DU:30104254 
RESEARCH Open Access
The impact of type 2 diabetes on health
related quality of life in Bangladesh: results
from a matched study comparing treated
cases with non-diabetic controls
Novie Safita1,2, Sheikh Mohammed Shariful Islam3,4,5*, Clara K. Chow5,6, Louis Niessen7,8, Andreas Lechner9,10,11,
Rolf Holle1,10 and Michael Laxy1,10
Abstract
Background: Little is known about the association between diabetes and health related quality of life (HRQL) in
lower-middle income countries. This study aimed to investigate HRQL among individuals with and without diabetes
in Bangladesh.
Methods: The analysis is based on data of a case-control study, including 591 patients with type 2 diabetes (cases)
who attended an outpatient unit of a hospital in Dhaka and 591 age -and sex-matched individuals without
diabetes (controls). Information about socio-demographic characteristics, health conditions, and HRQL were
assessed in a structured interview. HRQL was measured with the EuroQol (EQ) visual analogue scale (VAS) and the
EQ five-dimensional (5D) descriptive system. The association between diabetes status and quality of life was
examined using multiple linear and logistic regression models.
Results: Mean EQ-VAS score of patients with diabetes was 11.5 points lower (95 %-CI: −13.5, −9.6) compared to
controls without diabetes. Patients with diabetes were more likely to report problems in all EQ-5D dimensions than
controls, with the largest effect observed in the dimensions ‘self-care’ (OR = 5.9; 95 %-CI: 2.9, 11.8) and ‘mobility’ (OR = 4.
5; 95 %-CI: 3.0, −6.6). In patients with diabetes, male gender, high education, and high-income were associated with
higher VAS score and diabetes duration and foot ulcer associated with lower VAS scores. Other diabetes-related
complications were not significantly associated with HRQL.
Conclusions: Our findings suggest that the impact of diabetes on HRQL in the Bangladeshi population is much higher
than what is known from western populations and that unlike in western populations comorbidities/complications are
not the driving factor for this effect.
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Background
Diabetes is a major health problem all over the world
that leads to severe complications and disability [1].
Eighty percent of the world’s diabetic population lives in
low- and middle-income countries. South Asia is one of
the most affected regions [2] and with a prevalence of
around 9.7 %, Bangladesh is the country with the second
largest number of adults with diabetes in South Asia
showing increasing trend in both urban and rural areas
[3, 4]. Understanding the burden of diabetes in the
Bangladeshi population is essential for decision making
and resource allocation in the national healthcare sys-
tem. Health-related quality of life (HRQL) is an import-
ant patient-reported outcome that allows policy makers
to understand the burden of diabetes. HRQL compre-
hensively describes the patient’s health status comprising
physical, mental, emotional and social wellbeing [5]. The
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EQ-5D is a preference-based HRQL instrument that has
been used widely in diabetes research – particularly pre-
ferred because of its simplicity and reliability [6]. Assess-
ment of HRQL using generic instruments like the EQ-5D
allows burden of disease comparisons across a broad
spectrum of diseases and indications.
Several studies, mainly from high-and middle-income
countries, have described the negative impact of diabetes
on HRQL. It has been found that particularly individuals
with macro-vascular complications such as stroke and
ischemic heart disease often report substantial deteriora-
tions in HRQL [7–9]. Moreover, a comprehensive review
on this topic suggested a strong association between the
number and severity of complications with worsening
quality of life [10]. Other important determinants that
have been reported were patient’s awareness that they
have developed diabetes [11], insulin therapy [12], obes-
ity [12], and fear of hypoglycemic events [13].
Even though a great proportion of people with dia-
betes live in South Asia, there is little evidence on the
effect of diabetes on quality of life in this setting, espe-
cially in Bangladesh. The effect might be different to
what is already known from western populations, as in
Asia, people live in a different socio-economic context,
and develop diabetes at younger age and lower BMI
thresholds [14–17]. South Asians also tend to have a
greater risk of developing many diabetes-related compli-
cations such as coronary artery disease (CAD), periph-
eral artery disease (PAD), retinopathy, nephropathy, and
depression [18–20]. Given the high prevalence of dia-
betes and diabetic complications in South Asian popula-
tions, there is urgent need to assess and understand the
burden of diabetes in terms of reduced HRQL.
The objective of this study was therefore to estimate
the impact of type 2 diabetes on HRQL using data from
a large case-control study from Bangladesh. In an ex-
ploratory analysis, we further examined determinants of
HRQL among diabetes patients only.
Methods
Study design
The data of this study originates from a case-control
study comprising 591 patients with diabetes and 591
people without diabetes. Non-specialized and specialized
diabetes care in Bangladesh is predominantly delivered
in diabetes centers or outpatient care centers. Both cases
and controls were recruited in the Out-Patient Depart-
ment (OPD) of the Bangladesh Institute of Health Science
(BIHS) Hospital, a tertiary hospital in Dhaka, between
January and July 2014. The BIHS OPD serves patients
from various places and different socioeconomic back-
grounds, and has one of the largest diabetic Out-
Patient Department (OPD) turnover in the world
under a single roof.
Individuals coming to the OPD were included as
‘cases’ if they were diagnosed with type 2 diabetes ac-
cording to WHO criteria [21], willing to participate in
the study by providing necessary measurements, and
provide written informed consent. Exclusion criteria
were age younger than 20 years, patients with serious
co-morbid conditions, eg diabetic episodes, that require
immediate hospitalization, patients having mental illness,
or those who were unable to provide written consent.
Controls were recruited within 48 h after recruiting
index cases and were either visitors of the hospital or
people who live in the same geographical area as cases.
Eligible were individuals of the same sex and similar age
(within 5-years range) as cases, without a diabetes diag-
nosis, who agreed to participate by providing written
consent.
Data collection and instruments
Data were collected by a study team consisting of one
study physician, one research officer, and three research
assistants. The team underwent a 4 weeks training in
which they were taught about the study protocol and re-
search ethics and trained to perform the physical mea-
surements and interviews. Information on socioeconomic
status, history of diseases, diabetes-related conditions and
medications, as well as HRQL were collected through
face-to-face interviews using a structured questionnaire.
Biomedical and anthropometric information were assessed
in a standardized examination. Details on the study de-
sign, the protocol and data collection have been described
elsewhere [22].
Health related quality of life
HRQL was assessed using the Bengali translated version
of EuroQol 5 dimensions (EQ-5D) instrument. The EQ-
5D is a generic index instrument that is applicable to a
wide range of health condition. It comprises two parts:
the EQ-5D descriptive system and the EQ visual
analogue scale (EQ-VAS). The EQ-5D descriptive system
measures five health domains including mobility, self-
care, usual activities, pain/discomfort, and anxiety/de-
pression [23]. In the used 3 level version (EQ-5D-3 L),
for each of those health domains there are 3 responses
level, ie ‘no problems’, ‘moderate problems’, and ‘extreme
problems’. If a scoring algorithm, ie a reference value
set, is available the 243 resulting health states can be
converted into a single utility value, the EQ-5D index
score. If no reference value set is available, as it is the
case for the Bangladeshi population, a single item ana-
lysis is possible. The EQ-VAS is a vertical Visual Analog
Scale with a range from 0 (worst imaginable health state)
to 100 (best imaginable health state) scale. Both the EQ-
5D and the EQ-VAS evaluate the health status of re-
spondents on the day of survey.
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Socio-demographics factors and comorbidities
Three sets of covariates were defined. The first set in-
cludes the sociodemographic and life-style factors age
(continuous), gender, education (no education, primary
education, secondary education, higher secondary educa-
tion and above), income (categorized in quartiles), mari-
tal status (married, not married), employment status
(employed, not employed), smoking status (currently
smoking, not smoking) and weight status (underweight/
normal weight – body mass index (BMI) < 25, over-
weight – 25 ≤ BMI < 30, obese-BMI ≥ 30).
The second set of covariates includes the binary variables
heart disease (angina, myocardial infarction, heart failure or
coronary artery disease), kidney disease (kidney failure, ne-
phropathy or chronic kidney disease), neurological disease
(stroke, transient ischemic attack or peripheral neuropathy)
and eye problem (retinopathy, visual acuity or cataract).
The third set of covariates includes variables that are
only important for patients with diabetes, namely diabetes
duration and the presence of a foot ulcer. Selection of de-
terminants and covariates was based on evidence from the
literature and availability of information assessed.
Data Analysis
The characteristics of the study population were de-
scribed using descriptive statistics of means, standard
deviations, frequencies and proportions.
To analyze the association between diabetes and EQ-
VAS scores, we fitted a multiple linear regression model.
To examine the relationship between diabetes and EQ-5D,
the five dimensions that originally have three ordinal levels
(no, moderate, extreme problems) were dichotomized to
the categories ‘no problem’ and ‘moderate or extreme
problem’ and a multiple logistic regressions model was ap-
plied. Linear and logistic regression models were succes-
sively adjusted for the first (socio-demographics) and then
second set of covariates (comorbidities). Interaction effects
between diabetes and variables from the covariate set 1
were tested. To explore the determinants of quality of life
in patients with diabetes, in a second step, we applied a lin-
ear regression model in which we regressed the socio-
demographics (covariate set 1), comorbidities (covariate
set 2) and diabetes-related factors (covariate set 3) on the
EQ-VAS scores in cases only.
Data were complete for all variables, except for “income”
(n = 98 missing). To avoid shrinkage of data, missing values
were imputed with a single regression-based imputation
method (PROC MI). All analyses were performed using
the PROC GLM and PROC MI statements in SAS 9.3
(SAS Institute Inc., Cary, NC, USA).
Results
Table 1 shows the characteristics of the study popula-
tion. Cases and controls did not differ significantly in
terms of gender, BMI, and income, however, there was a
small (0.8 years) but statistical significant difference in
the matching criterion age, which probably results from
the frequency matching using 5-year age bands. Patients
with diabetes were more likely to be unemployed, suf-
fered more often from cardiovascular, nephrological,
neurological and eye-related diseases and were less likely
to smoke or to be married. In cases, duration of diabetes
averaged 7.7 years and 50 % of patients reported to suf-
fer from at least one comorbidity or complication.
Table 1 Characteristics of study participants
Variables Diabetic
subjects
(n= 591)
Non-diabetic
subjects
(n= 591)
p-value
Demographics
Age; mean [SD] 51.3 [11.6] 49.5 [11.1] 0.0043*
Sex 1.000
Male; n (%) 255 (43.1) 255 (43.1)
Female; n (%) 336 (56.9) 336 (56.9)
BMI; mean [SD] 26.4 [3.9] 26.0 [7.0] 0.217*
Normal-underweight; n (%) 229 (38.7) 253 (42.8)
Overweight; n (%) 274 (46.4) 271 (45.9)
Obese; n (%) 88 (14.9) 67 (11.3)
Education years; mean [SD] 7.8 [5.3] 9.1 [5.2] <.0001*
No education; n (%) 116 (19.6) 76 (12.9)
Primary education; n (%) 103 (17.4) 96 (16.2)
Secondary education; n (%) 190 (32.2) 178 (30.1)
Higher secondary and
above; n (%)
182 (30.8) 241 (40.8)
Income taka; mean [SD] 16605 [17096] 16629 [18825] 0.9827 *
Married; n (%) 476 (80.5) 517 (87.5) 0.0011**
Unemployed/retired; n (%) 91 (15.4) 49 (8.3) 0.0002 **
Cigarette smoking; n (%) 114 (19.3) 144 (24.4) 0.0346 **
Chronic conditions
Cardiovascular disease; n (%) 59 (10.0) 20 (3.4) <.0001**
Kidney disease; n (%) 53 (9.0) 14 (2.4) <.0001**
Neurological disease; n (%) 35 (6.0) 11 (1.9) 0.0003**
Eye disease; n (%) 355 (60.1) 225 (38.1) <.0001**
Foot ulcer; n (%) 20 (3.4) 0 (0.0) <0.001**
Number of complications; - <0.001**
0; n (%) 191 (32.3) 352 (59.6)
1; n (%) 298 (50.4) −212 (35.9)
> 1; n (%) 102 (17.3) −27 (4.6)
Diabetes duration; mean [SD] 7.7 [7.2] -
< 5 years; n (%) 252 (42.6) -
5–10 years; n (%) 148 (25.1) -
> 10 years; n (%) 191 (32.3) -
*p-values from t-test; **p-values from Chi-square test
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Association between diabetes and EQ-VAS
The unadjusted EQ-VAS mean in patients with diabetes
was 69.0 (SD = 19.2), compared to 81.5 (SD = 15.3) in
controls without diabetes. Table 2 depicts the results on
the association between diabetes and HRQL. The first
model, adjusted for sociodemographic variables explains
18.4 % of the variance and shows that the adjusted EQ-
VAS mean in patients with diabetes was 11.5 points lower
than in people without diabetes [95 % CI = −13.5; −9.6].
After adjustment for comorbidities R2 improved to 19.2 %,
yet diabetes was still by far the strongest predictor for
HRQL (β = −10.7 [95 % CI = −12.7; −8.6]). Interaction ef-
fects were only found for the factor unemployed/retired
(p = 0.001). In individuals who reported to be retired/un-
employed the impact of diabetes was much smaller (− 2.6
points) than in the working population (−12.6 points)
(Appendix).
Association between diabetes and dimensions of the EQ-5D
Figure 1 descriptively illustrates the percentage of indi-
viduals with and without diabetes who report moderate
or severe problems in the EQ-5D dimensions. Most
problems were reported in the dimensions pain/dis-
comfort (cases 58 %, controls 24 %, difference 25 %)
and anxiety/depression (cases 47 %, controls 34 %, dif-
ference 13 %) followed by mobility (cases 25 %, controls
6 %, difference 19 %), usual activities (cases 14 %, con-
trols 4 %, difference 10 %) and self-care (cases 10 %,
controls 2 %, difference 8 %). Table 3 shows the ad-
justed odds ratios (ORs) of reporting moderate or se-
vere problems within each of the EQ-5D dimensions in
cases with diabetes compared to controls without dia-
betes. The adjusted OR estimates vary between 1.6 and
5.8 in the basic model. In the comorbidity-adjusted
model ORs were slightly lower. In contrast to the abso-
lute differences in proportion of reported problems, the
largest relative effect was observed for the dimensions
self-care (OR = 5.8).
Determinants of EQ-VAS in patients with diabetes
Determinants of HRQL in patients with diabetes are
illustrated in Table 4. The full model explained
Table 2 Regression coefficients from multiple linear regression analysis on the association between diabetes status and
EQ-VAS score
Basic model (R2 = 0.184) Extended model (R2 = 0.192)
Covariates β-coefficients [95 % CI] p-value β-coefficients [95 % CI] p-value
Intercept 79.3 [73.0; 85.6] <.0001 78.1 [71.8; 84.5] <.0001
Diabetes −11.5 [−13.5; −9.6]* <.0001 −10.7 [−12.7; −8.6]* <.0001
Age −0.2 [−0.3; −0.1]* 0.0009 −0.1 [−0.2; 0.0]* 0.0142
Male (ref = female) 4.7 [2.4; 7.0]* <.0001 4.6 [2.3; 6.9]* <.0001
BMI (ref = <25)
Overweight (25–30) 0.9 [−1.2; 3.0] 0.392 1.0 [−1.1; 3.0] 0.3619
Obese (>30) −1.1 [−4.2; 2.0] 0.4865 −0.9 [−4.0; 2.2] 0.5596
Education (ref = no formal education)
Primary 3.4 [0.1; 6.8]* 0.0462 3.7 [0.3; 7.0]* 0.0333
Secondary 4.4 [1.4; 7.5]* 0.0044 4.8 [1.7; 7.9]* 0.0021
Higher secondary and above 7.4 [4.1; 10.6]* <.0001 7.7 [4.4; 11.0]* <.0001
Income (ref = Q1)
Q2 2.4 [−0.4; 5.1] 0.0875 2.3 [−0.4; 5.1] 0.0943
Q3 2.3 [−0.5; 5.1] 0.1079 2.4 [−0.4; 5.2] 0.0934
Q4 5.0 [2.1; 7.9]* 0.0008 5.1 [2.2; 8.0]* 0.0006
Married (vs single) 0.8 [−1.9; 3.5] 0.5763 0.7 [−2.0; 3.3] 0.6334
Unemployed/retired −0.7 (−4.1; 2.7] 0.6743 −0.7 [−4.1; 2.7] 0.6972
Smoking 0.1 [−2.4; 2.5] 0.9459 0.3 [−2.2; 2.7] 0.8398
Comorbodities
CVD - −2.0 [−6.0; 2.0] 0.3269
Kidney_disease - −2.6 [−6.8; 1.6] 0.2302
Neuro_disease - −4.3 [−9.4; 0.7] 0.0935
Eye_problem - −2.1 [−4.1; 0.0]* 0.0479
Results from multiple linear regression based on n = 591 cases and n = 591 controls; *p-value <0.05
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10.8 % of the variance. HRQL was positively associ-
ated with male gender (β = +4.2), highest education
level (β = +6.4), and belonging to the highest income
quartile (β = +5.7). Compared to patients with a dia-
betes duration <5 years, those with a duration of 5–
10 years and those with a duration of >10 years re-
ported 4.7 (p = 0.02) and 6.3 (p < 0.001) point lower
VAS scores. Neither weight status nor comorbidities
such as heart disease, neurological disease, and renal
disease and eye problems were significantly associated
with EQ-VAS scores. However, diabetic foot ulcer had
a large negative impact on HRQL (β = −13.5 [95 %
CI = −21.9; −5.1]).
Discussion
HRQL is an important patient-reported outcome that
helps policy makers to understand the burden of dis-
eases. There is a lack of evidence concerning the bur-
den of diabetes on quality of life among South Asian
populations. To the best of our knowledge, this study
is the first to analyze the association between diabetes
Fig. 1 Proportion of patients reporting moderate or severe problems in the EQ-5D dimensions
Table 3 Adjusted odds ratios (ORs) of reporting moderate
or severe problems within each of the EQ-5D dimensions
in patients with diabetes compared to people without
diabetes
EQ-5D dimensions Model 1 Model 2
OR (95 % CI) OR2 (95 % CI)
Mobility 4.5 [3.0–6.6] 3.7 [2.5–5.6]
Self-care 5.9 [2.9–11.8] 5.2 [2.6–10.6]
Usual activities 3.3 [2.0–5.3] 3.0 [1.8–5.0]
Pain/discomfort 4.0 [3.1–5.2] 3.5 [2.7–4.6]
Anxiety/depression 1.7 [1.3–2.1] 1.6 [1.2–2.0]
Results based on multiple linear logistic regression models based on n = 591
cases and n = 591 controls. Model 1: adjusted for covariate set
1 (socio-demographics)
Model 2: adjusted for covariate set 1 (socio-demographics) and set
2 (comorbidities)
All p-values <0.001
Table 4 Regression coefficients from a multiple linear
regression analysis model analyzing determinates of EQ-VAS
score
Parameter β-coefficients [95 % CI] P-value
Intercept 63.1 [57.5; 68.7] <.0001
Male (ref = female) 4.2* [0.5; 7.9] 0.0281
BMI (ref = normal)
Overweight 1.6 [−1.8; 4.9] 0.3586
Obese 1.4 [−3.4; 6.2] 0.5633
Education (ref = no formal education)
Primary 2.4 [−2.6; 7.4] 0.3466
Secondary 3.6 [−0.8; 8.0] 0.1113
Higher secondary and above 6.4* [1.5; 11.4] 0.0113
Income (ref = Q1)
Q2 2.8 [−1.5; 7.1] 0.1991
Q3 3.4 [−1.0; 7.9] 0.1265
Q4 5.7* [1.3; 10.1] 0.0113
Married 0.6 [−3.4; 4.5] 0.7766
Unemployed/retired 3.2 [−1.5; 8.0] 0.1846
smoking 1.0 [−2.9; 4.9] 0.6167
Diabetes duration (ref = <5 years)
5–10 years −4.7* [−8.5; −0.8] 0.0180
> 10 years −6.3*[−9.9; −2.6] 0.0009
Comorbidities
Cardiovascular diseases −2.0 [−7.2; 3.2] 0.4490
Kidney diseases −1.4 [−6.8; 4.0] 0.6017
Neurological diseases −4.5 [−11.0; 1.9] 0.1691
Eye problems −0.6 [−3.8; 2.6] 0.7195
Foot ulcer −13.5*[−21.9; −5.1] 0.0017
R2 of the model = 0.108; *p-value <0.05
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and HRQL in Bangladesh. Our findings suggest that
the impact of diabetes on HRQL in the Bangladeshi
population is much higher than what is known from
western populations and that unlike in western popu-
lations comorbidities/complications are not the driv-
ing factor for this effect [24–28].
The results of this study show that patients with dia-
betes report lower VAS-scores than controls without
diabetes. Qualitatively, this finding from this case-
control study is in line with results from population-
based studies from other parts of the world; however,
the magnitude of the effect is much bigger in the Ban-
gladeshi population. With a decrement of almost 12
points on the VAS the effect is around twice as big as
what has been found in studies in the US, Germany,
China and Korea in which quality of life decrements for
diabetes averaged 5–7 points on the VAS [24–28].
Comorbidities were much more prevalent in cases, as
diabetes is a strong independent risk factor for many of
those. Though, the strong effect of diabetes on HRQL
was not or only weakly mediated by self-reported micro-
and macrovascular comorbidities as regression coeffi-
cients did not significantly change after adjustment for
comorbidities. This is in contrast to studies from west-
ern countries which showed that micro- and macrovas-
cular complications have a huge impact on HRQL in
both patients with and without diabetes and are there-
fore the main causes for lower HRQL values in patients
with diabetes [8, 12, 24, 29].
A recent study on the same data showed that out of
pocket payments for medication and treatment are for
example much higher than in China or other coun-
tries [30]. In parallel to the economic burden, this
study shows that also the diabetes associated HRQL
decrement is much higher than observed in other
countries and populations. The reason for this finding
remains unknown. It might be possible that the high
out of pockets costs for diabetes medications and time
resources spend for the management of the disease
put individuals under financial pressure, resulting in
psychologic and physical stress that translates into
lower perceived HRQL. The found discrepancy in the
magnitude of effect size could also be partly related to
other issues: Participants in this study were slightly
younger than those in the other mentioned studies
and it is known that the difference in HRQL between
patients with and without diabetes diminishes with
age [24–28, 31]. Further, population-based HRQL
studies often rely on self-reports of the diabetes status
and therefore the found associations might be diluted.
This is unlikely to have happened in this case-control
study, as objectively measured WHO criteria for dia-
betes were applied. Finally, compared to population-
based surveys both cases and controls were recruited
in a tertiary hospital OPD. Although diabetes care in
Bangladesh is predominantly delivered in such set-
tings, it might be possible that patients visiting the
hospital OPD are ‘more severe’ cases. However, as the
prevalence of diabetic complications is not higher
than those known from other population-based stud-
ies on routinely treated diabetes patients, this bias is
expected to be rather small [32].
The reason for the low predictive value of comor-
bidities and complications compared to the diabetes
status remains unknown. Whereas it is possible that
people from Bangladesh simply value factors like
renal or cardiovascular comorbidities less burden-
some than in other parts of the world, discrepancies
could be also related to unknown differences in as-
sessment methods. In our study, for example, infor-
mation on comorbidities were based on self-reports
and various conditions were summarized in the pro-
vided answer categories.
Besides these mentioned discrepancies, our findings
are generally consistent with those of previous studies
from Western or other Asians countries. In our study,
being male, having higher education level and belonging
to the highest income group, are positively associated
with HRQL, whilst older age is associated with lower
quality of life. This is accordance with the literature and
illustrates that particularly females and people with low
socioeconomic status report lower HRQL scores [9, 12,
33, 34]. With pain/discomfort being the most frequently
reported problem the results of this study are in line
with other studies from various populations [7, 35–38].
In addition, as reported in previous studies we found
that diabetic foot ulcer was associated with a very high
HRQL decrement [36, 39]. These issues indicate that
neuropathic problems in legs/feet and management of
the legs are a core problem that should be addressed in
the Bangladeshi population. Regular check-up of feet,
screening for neuropathy, and adequate patient self-
management education could be cost-effective strategies
in this context.
The strengths of this study are the case-control de-
sign, the large sample size of diabetes patients, the
unbiased classification of diabetes and the standard-
ized assessment of HRQL with the EQ-5D descriptive
system and the EQ-VAS. Furthermore, the stepwise
adjustment for sociodemographic factors and comor-
bidities and the analysis of both, the impact of dia-
betes on HRQL, and the determinants of HRQL in
patients with diabetes enhances the understanding for
potentially underlying mechanisms in a high level of
detail.
Yet, there are a few limitations that need to be con-
sidered when interpreting the results of the study.
Firstly, all co-morbid conditions in this study are self-
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reported-hence misclassifications issues are likely to
have had occurred. We further did not take into ac-
count the time of occurrence of comorbidities and
some might already be cured by the time this study was
conducted. In addition, it has to be acknowledged that
this study compares quality of life of patients receiving
care from a tertiary OHD with the quality of life of
people without diabetes. The results of this study on
the impact of diabetes on HRQL are therefore only
generalizable to people who are aware of their disease,
and who are under regular or sporadic care. This is a
limitation, as previous studies indicated that only
around 56 % of patients are aware of their disease and
only 40 %, ie around 71 % of those who are aware of
their disease, receive regular diabetes care [40]. Another
minor limitation that has to be acknowledged is that po-
tential cases or controls that require hospitalization were
not considered to be eligible for the study. This explicit
exclusion criterion leads to a minor underrepresentation
of cases with severe episodes.
Finally, although the EQ-5D index score is known
to be a valid and a reliable generic instrument to as-
sess HRQL [6, 41], the results of our main analysis
rely primarily on the less frequently used EQ-VAS.
The reason for this is that there is no population-
based Bangladeshi value set/scoring algorithm avail-
able that allows calculating a country-specific single
utility score. Whereas estimations on basis of utility
values describe the burden of a disease from a soci-
etal perspective, analyses on basis of VAS scores de-
scribe the burden of the disease from the perspective
of the examined population, ie from the perspective
of patients with diabetes. Furthermore, in contrast to
EQ-5D index scores which are indirectly derived via
the methods time trade-off or standard gamble, the
valuations via the VAS do neither express preferences
nor are they made under conditions of uncertainty.
Therefore, VAS scores do not fulfill the assumptions
of expected utility theory and cannot be interpreted
as utilities needed as input parameters for decision
analytic models.
Conclusion
The burden of diabetes in terms of lower HRQL in
Bangladesh is substantial and much larger as what has
been found in other Asian, European or North American
countries. Female gender, low education, low income a
long diabetes duration and presence of diabetic foot ulcer
were significant predictors for reduced HRQL in pa-
tients with type 2 diabetes. Secondary preventive efforts
are needed and socioeconomic boundaries for treatment
should be lowered to diminish the burden of diabetes
and diabetic complications such as foot ulcer.
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